RUTI Immune logra €1,6 millones a través de Capital Cell para desarrollar la vacuna RUTI® para COVID-19 y otras infecciones respiratorias

by Capital Cell

La compañía RUTI Immune, creada por la biotecnológica Archivel Farma, ha logrado captar 1,6 millones de euros a través de la plataforma de inversión colectiva Capital Cell para financiar su inves...

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

YIELCO Investments Celebrates Its 15th A...

by YIELCO Investments AG

Since its foundation in 2011, YIELCO has evolved into an international...

Photos Stream